rTMS for Apathy Clinical Trial
NCT: NCT05561205 · RECRUITING
Brief Summary
Apathy is a common, early, and disabling symptom in dementias and mild behavioural impairment such as Alzheimer's disease (AD) and is characterized by lack of interest and enthusiasm. Both repetitive transcranial magnetic stimulation (rTMS), a form of non-invasive brain stimulation, and methylphenidate, a medication, have been shown to improve apathy. This pilot study will investigate rTMS as a treatment for apathy in neurocognitive disorders and mild behavioural impairment in individuals receiving methylphenidate and individuals not receiving medication for apathy.
Frequently Asked Questions
What is rTMS for Apathy Clinical Trial?
rTMS for Apathy Clinical Trial is a clinical trial registered under NCT05561205. Current status: RECRUITING.
What is the status of NCT05561205?
The current status of NCT05561205 (rTMS for Apathy Clinical Trial) is: RECRUITING.
When did rTMS for Apathy Clinical Trial start?
rTMS for Apathy Clinical Trial started on 2023-02-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.